Verrica Pharmaceuticals Inc (VRCA) — Financial Flexibility Index
Verrica Pharmaceuticals Inc (VRCA) has a Financial Flexibility Index of -0.29x as of June 2026. Free cash flow of $-9.28 Million (operating CF $-9.28 Million minus capex $0.00) represents 0% of total liabilities ($31.71 Million). Check how aggressively does Verrica Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verrica Pharmaceuticals Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Verrica Pharmaceuticals Inc across 10 annual periods. For the full cash flow conversion analysis, see Verrica Pharmaceuticals Inc cash conversion from operations.
Annual Financial Flexibility Index for Verrica Pharmaceuticals Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Verrica Pharmaceuticals Inc. Explore Verrica Pharmaceuticals Inc (VRCA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.79x | $-17.63 Million | $-17.63 Million | $22.39 Million | ▲ +17.3% |
| 2024 | -0.95x | $-60.90 Million | $-60.93 Million | $63.99 Million | ▼ -54.0% |
| 2023 | -0.62x | $-38.22 Million | $-38.58 Million | $61.83 Million | ▲ +84.2% |
| 2022 | -3.91x | $-18.35 Million | $-18.65 Million | $4.69 Million | ▼ -596.6% |
| 2021 | -0.56x | $-26.70 Million | $-27.58 Million | $47.52 Million | ▲ +19.5% |
| 2020 | -0.70x | $-28.74 Million | $-30.21 Million | $41.17 Million | ▲ +91.1% |
| 2019 | -7.84x | $-26.73 Million | $-27.41 Million | $3.41 Million | ▼ -13.6% |
| 2018 | -6.90x | $-17.10 Million | $-17.87 Million | $2.48 Million | ▼ -2822.3% |
| 2017 | -0.24x | $-3.81 Million | $-4.58 Million | $16.12 Million | ▲ +9.5% |
| 2016 | -0.26x | $-837.00K | $-1.61 Million | $3.21 Million | — |